Treatment Patterns, Statin Intolerance, and Subsequent Cardiovascular Events Among Japanese Patients With High Cardiovascular Risk Initiating Statin Therapy
| Autor: | Saurabh P Nagar, Kathleen M. Fox, Pratik P. Rane, Yi Qian, Juliana Meyers, Hyoe Inomata, Anne Beaubrun, Kouji Kajinami, Keith L. Davis |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male medicine.medical_specialty Statin medicine.drug_class Comorbidity 030204 cardiovascular system & hematology Cohort Studies 03 medical and health sciences 0302 clinical medicine Ezetimibe Japan Diabetes mellitus Internal medicine medicine Humans 030212 general & internal medicine Medical prescription Practice Patterns Physicians' Aged Retrospective Studies Atherosclerotic cardiovascular disease business.industry Drug Substitution Incidence (epidemiology) Incidence nutritional and metabolic diseases Retrospective cohort study General Medicine Drug Tolerance Middle Aged medicine.disease Atherosclerosis Diabetes Mellitus Type 2 Cardiovascular Diseases Cohort Female Hydroxymethylglutaryl-CoA Reductase Inhibitors Cardiology and Cardiovascular Medicine business medicine.drug |
| Zdroj: | Circulation journal : official journal of the Japanese Circulation Society. 82(4) |
| ISSN: | 1347-4820 |
| Popis: | Background This study examined treatment patterns, possible statin intolerance, and incidence of cardiovascular events (CVEs) in 2 cohorts of patients with high cardiovascular risk (i.e., patients with atherosclerotic cardiovascular disease [ASCVD] and patients with diabetes mellitus).Methods and Results:A retrospective cohort study examined adults initiating either a statin or ezetimibe from 1 January 2006 to 31 May 2014 in the Japan Medical Data Center database. The first observed statin or ezetimibe prescription defined the index date. Patients had ≥12 months of pre- and post-index date plan enrollment. Two high-risk cohorts, the ASCVD cohort and diabetes cohort, were created based on diagnoses observed during the 12 months' pre-index date. Treatment patterns, possible statin intolerance, and incidence of CVEs were reported. In the ASCVD cohort (n=5,302), 32.9% discontinued therapy, 7.7% switched to a non-index statin or non-statin lipid-lowering therapy, and 11.2% augmented index therapy in the 12 months' post-index date; only 0.3% were using high-intensity statins and 10% had possible statin intolerance. Also, 8.1% had any new CVE during the follow-up period. Treatment patterns and incidence of CVEs among the diabetes cohort were similar to those of the ASCVD cohort. Conclusions High cardiovascular risk Japanese patients had frequent treatment modifications, although use of high-intensity statin doses was rare. These patterns may indicate that alternative therapies for lipid lowering are needed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|